Identify neuronal signatures that distinguish FXS patients with distinct EEG phenotypes

The Department of the Army Medical Command awarded a $1,724,662 Project Grant to the University of Wisconsin-Madison under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to identify neuronal signatures that distinguish Fragile X syndrome patients exhibiting distinct electroencephalogram phenotypes. The University of Wisconsin System, doing business as Research and Sponsored Programs, will perform the work over a four-year period ending July 31, 2026. Through neuroscience research supported by this grant, the awardee aims to advance understanding and treatment of Fragile X syndrome, a genetic condition and leading cause of inherited intellectual disability. Findings may help the Military Medical Research and Development program fulfill its mission of transforming military and public health through innovative medical solutions.